In line with this, adenosine in the TME has been shown to inhibit the anti-tumor function of various immune cells, including cytotoxic T cells and natural killer cells, by binding to cell surface adenosine A2A receptors (34).. The gene discussed is ADORA2A; the disease is neoplasm.